Skip to content

Study on optimal dosage of propofol combined with dexmedetomidine for the opioid-free anesthesia induction

Study on optimal dosage of propofol combined with dexmedetomidine for the opioid-free anesthesia induction

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089952
Enrollment
Unknown
Registered
2024-09-20
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

surgery

Interventions

A:The dose of dexmedetomidine is 0.6mcg/kg of actual body weight.
B:The dose of dexmedetomidine is 0.8mcg/kg of actual body weight.
C:The dose of dexmedetomidine is 1.0mcg/kg of actual body weight.

Sponsors

Zhongshan Hospital,Fudan University(Xiamen Branch)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1 Patients undergoing elective surgery 2 Aged 18-60 3 ASA classification I-II 4 BMI between 18-30 5 Anesthesia method: general anesthesia with single-lumen endotracheal tube (7 or 7.5) 6 No major organ dysfunction, cardiopulmonary, liver and kidney function basically normal 7 Voluntary participation and signing of informed consent

Exclusion criteria

Exclusion criteria: ?Patients with a history of difficult endotracheal intubation ?Patients with a history of anesthetic allergy ?Patients with severe cardiovascular disease (New York Heart Association NYHA III-IV) or severe arrhythmia ?Patients receiving sedative or opioid medication ?Patients unable to fully understand and follow the trial process

Design outcomes

Primary

MeasureTime frame
Positive reaction;

Countries

China

Contacts

Public ContactChao Liang

Zhongshan Hospital,Fudan University(Xiamen Branch)

liang.chao@zs-hospital.sh.cn+86 159 2167 9955

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026